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Specific pathogen-free calves were inoculated intranasally
with one of seven strains of bovine herpesvirus 1.1 (BHVl.1) to
identify a highly virulent strain for use in vaccination-
challenge experiments. The calves were monitored clinically
and virologically. Clear differences in virulence between the
strains were observed. The Iowa strain was the most virulent;
the four calves infected with the strain had the most severe
clinical signs; two of them died and viraemia was detected in
three of them. To evaluate the immunogenicity of the seven
strains all the calves were challenged 16 weeks later with the
Iowa strain. The calves of a control group showed the typical
signs of a BHV1 infection, whereas all the other calves were
protected against disease and shed little or no virus. Hence,
the differences in virulence were not associated with differ-
ences in immunogenicity. After the calves had been treated
with dexamethasone, differences were observed between the
strains in the amount of virus that was excreted.
BOVINE herpesvirus 1 (BHVI) is an important pathogen of cattle.
Infectious bovine rhinotracheitis (IBR) is the most common sign of
a BHV1 infection (Gibbs and Rweyemamu 1977). Infectious pustu-
lar vulvovaginitis and infectious pustular balanoposthitis are also
caused by BHV1, but are less severe than IBR. The outcome of a
BHVI infection can vary from subclinical (Van Oirschot and others
1993) to a systemic infection in neonatal calves, sometimes result-
ing in death (Higgins and Edwards 1986).
BHVI strains are classified into several genotypes (Misra and
others 1983, Metzler and others 1985). Strains of the BHV1.1 geno-
type are isolated predominantly from the respiratory tract and
strains of the BHV1.2b genotype from the genital tract, but both
genotypes can cause infections of both tracts. Differences in viru-
lence have been observed between strains of the different geno-
types (Msolla and others 1983a, Edwards and others 1991).
The virulence and immunogenicity of seven strains within the
BHV I.I genotype were compared in order to identify a highly viru-
lent strain for use in challenge experiments and to select a highly
immunogenic strain with low virulence as a parental strain for
future vaccines. The establishment of latency was also studied
because it may be an important characteristic for future vaccines.
Latent virus can be reactivated by stress or by treatment with dexa-
methasone (Rock and others 1992) and as a result the virus can be
excreted. Studies of the differences between the strains in the
extent of excretion of virus after treatment with dexamethasone
were also made.
Materials and methods
Virus strains and cells
Embryonic bovine tracheal cells (EBTr) were used for virus iso-
lation and titration assays and for neutralising antibody tests. The
cells were cultured with Earle's minimal essential medium with 2
to 10 per cent BHVl-negative calf serum from the institute's spe-
cific pathogen-free (SPF) herd, and 0-2 per cent of an antibiotic
stock solution containing 27,000 iu penicillin-G, 27 mg strepto-
mycin, 7000 iu nystatin and 7 mg kanamycin/ml.
Seven strains of BHVI.l were selected for the experiment: strain
Lam and strain Harberink were isolated from outbreaks of IBR in
the Netherlands in 1972 and 1987, respectively; strain Iowa has
been described as causing lesions of the reproductive tract and
early embryonic death (Miller and Van Der Maaten 1984); BHV1
strain 108 has caused fatal multisystemic infections of newborn
calves (Mechor and others 1987); the EDI strain has a genotype
that is predominant in Great Britain (Edwards and others 1990);
and the seventh strain of BHVI (Espuna) was isolated in 1988 from
an outbreak of IBR in central Spain. All the strains were plaque
purified three times. Virus was grown on EBTr cells to obtain
stocks with titres of 108 TCID50/ml or more. The stocks were
stored at -70°C until use. Restriction enzyme analysis was used to
verify the genotypes. The viruses and cells were free from bovine
viral diarrhoea virus.
Experimental design
Thirty-two calves were delivered by caesarean section, all with-
in one week. They were deprived of colostrum and kept in identi-
cally conditioned stables with a filtered air supply. Everyone
entering the stables changed clothes and put on a surgical mask,
cap and gloves to reduce microbiological contamination. Because
colostrum-deprived calves are very susceptible to neonatal infec-
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tions, all the calves were treated with antibiotics until the start of
the experiment. At the start of the experiment two control calves,
one calf infected with the Lam strain and one calf infected with
the Iowa strain continued to be treated, because they had
omphalophlebitis and arthritis. The calves were fed milk replacer
twice daily for six weeks and then gradually weaned on to a diet
of calf concentrates and grass pellets.
The calves were allotted to eight groups of four calves. At
approximately two weeks of age the calves of seven of the groups
were infected, each with a different strain. Each calf received a
total of 8 x 107 TCID50 by intranasal spray. The eighth group
served as uninfected controls. Sixteen weeks after infection, all
the calves were challenged intranasally with the most virulent
strain, the route of infection and the dose being the same as when
they were first infected. Six weeks after the challenge all the
calves were treated intramuscularly with dexamethasone, 0.1
mg/kg bodyweight, for five consecutive days to reactivate any
putatively latent BHV1.
Clinical observations
The calves were examined before infection, on the day of infec-
tion, daily for 10 days, and 13, 15 and 17 days after the infection,
after the challenge and after the start of the dexamethasone treat-
ment. The calves' respiratory rate, heart rate and rectal tempera-
ture were recorded, and their behaviour, appetite, cough and stri-
dor and the conditions of their nasal, ocular and oral mucosae
were also recorded in order to evaluate objectively the differences
in the severity of disease caused by the infections with the differ-
ent strains. A clinical score was obtained as described by
Kaashoek and others ( 1994).
Virological and serological examinations
Samples for virological examination were collected on the days
when the calves were examined clinically. The nasal, ocular and
vaginal swabs were eluted in 3 ml sample medium (Hanks' mini-
mal essential medium containing 2 per cent of the antibiotic stock
and 2 per cent SPF calf serum). The calves' prepuces were rinsed
with 50 ml sample medium. After clarifying the samples, two lots
of one ml of each sample were stored at -70°C. Serum samples
for virus isolation and neutralising antibody tests were stored
undiluted. One ml of each sample was tested on monolayers of
EBTr cells for the presence of virus. The samples positive in BHVI
isolation tests were titrated in microtitre plates. The virus titres
were calculated and expressed as log10 TCID50/ml of nasal, ocular
or genital fluid or serum.
Serum samples collected before infection and on days 10, 20
and 35 after infection, on the day of challenge and regularly there-
after were tested in serial two-fold dilutions in a 24-hour BHVI
neutralisation test (Kaashoek and others 1994).
DNA isolation and restriction enzyme analysis
DNA was isolated as described by Van Oirschot and others
(1995) and used for restriction enzyme analysis. Restriction
enzyme digests were made under the conditions recommended by
the manufacturers (GibconRL) and the DNA fragments were sepa-
rated on a 0-5 per cent agarose gel as described by Van Oirschot
and others (1995). As a molecular weight marker the 1 kb DNA
ladder of GibcoBRL was used. The gels were stained with ethidi-
um bromide and photographed under short-wave ultraviolet light.
Post mortem examinations
A gross pathological examination was made of the calves that
died during the experiment. Samples for virus isolation were col-
lected from the nasal and pharyngeal mucosae, trachea, tonsils,
major lymph nodes of the respiratory tract, spleen, liver, kidneys
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FIG 1: Rectal temperature (a) and clinical score (b) after infection.
Groups of four calves were infected intranasally with one of seven
BHV1.1 strains; Lam (*), Harberink (0), Iowa (0i), 108 (A), Cooper-1
(-), ED1 (-) or Espuna (-). The calves of the control group (- -)
were not infected. Each line indicates the average values for a group.
Two of the calves infected with Iowa died on day 10, after which the
average of the two remaining calves is shown
and adrenals. From these tissues, 10 per cent weight/volume
suspensions were made in sample medium. After clarification,
1 ml of each sample was tested for virus on monolayers of EBTr
cells. Standard bacteriological examinations were made of the
same tissues.
Statistical methods
The results were evaluated statistically by analysis of variance.
The least significant difference for P=0.05 was determined.
Comparisons were made within the groups from day to day, and
comparisons were made between the groups. The statistical evalu-
ations were made using Statistix (Analytical Software). The term
significant' in the text mean statistically significant (P<0.05).
Results
Clinical observations
The respiratory rates and the heart rates after the infection var-
ied widely from day to day, and no obvious effect of the BHV 1
infection was observed. On day two the rectal temperatures of the
infected calves started to increase (Fig la). The highest tempera-
tures were recorded on days four and five. Fever (240°C) was
recorded for four or more days in the calves infected with the
Iowa, the EDi and the Espuna strains and for two to three days in
the other infected calves.
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FIG 2: Nasal (a), ocular (b) and genital (c) virus shedding after infec-
tion. Key as in Fig 1
The calves infected with the Iowa, the EDI and the Espuna
strains showed severe signs of illness; apathy, loss of appetite,
rhinitis, nasal discharge, lesions of the nasal mucosae and nasal
stridor were often observed. Milder signs of illness were observed
in the other infected calves. In all the groups coughing, either
spontaneous or during the handling of the calves, was rarely
heard. On day 10, two of the calves infected with the Iowa strain
died. The two remaining calves of this group were very sick, but
recovered quickly thereafter. Two calves infected with the EDI
strain were also very sick, and they recovered more slowly. As a
result, the calves infected with the Iowa or the EDI strain had very
high clinical scores (Fig lb). The clinical scores for the other
groups were lower. The average total clinical scores for the calves
infected with the Lam or the Harberink strain were significantly
lower than the scores for the calves infected with the Iowa or the
EDI strain.
At challenge, all the calves were infected with the Iowa strain,
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FIG 3: Nasal (a) virus shedding after challenge, and the nasal (b) and
ocular (c) virus shedding after dexamethasone treatment. Key as in
Fig 1
because this strain was considered to be the most virulent of the
seven strains. The respiratory rate and the heart rate of the 18-
week-old calves were more uniform but, again, no effect of the
infection could be observed. The rectal temperatures of the control
calves started to increase after day two and were highest (41 1°C)
on day four. The fever lasted for three days. The calves of the
control group lost their appetite, were apathetic and had lesions of
the nasal mucosa. The clinical signs were less severe than at the
first infection; the average daily clinical score was always less
than 15 and the total clinical score in the 18-week-old calves was
significantly lower than in the two-week-old calves that were
infected with the Iowa strain. The other calves remained healthy
and fever was never recorded.
After treatment with dexamethasone, a slight fever was record-
ed for one or two days in one calf infected with the Cooper-I
strain and one calf infected with the EDI strain. No other clinical
signs of disease were observed.
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Virological findings
No virus was isolated either from the samples collected before
the infection or from the control calves before the challenge.
Virus was isolated from the noses of most of the infected calves
for a mean (sd) period of 9.8 (0-4) days, but for 8-8 (1.0) days
from the calves infected with strain 108 (Fig 2a). The total amount
of virus shed by the calves infected with strain 108 was signifi-
cantly less than the total amount of virus shed by the other calves.
The calves infected with the Harberink strain shed virus for the
longest period and shed the largest amounts. Ocular virus shed-
ding started on day two for the calves infected with the ED 1 or the
Espuna strain and on day three for the calves infected with one of
the other strains (Fig 2b). Again, the calves infected with strain
108 shed less virus for a shorter period than the other calves, but
the difference was not significant. Virus was isolated from the
genital mucosae between day two and day 10 from all the infected
calves, except from one of the calves infected with strain 108.
Small amounts of virus were isolated from the genital mucosae of
the calves infected with the Harberink strain, strain 108 or the
Cooper-I strain. Larger amounts of virus were isolated from the
genitals of the other infected calves (Fig 2c).
Virus was isolated from the serum samples of one calf infected
with the Espuna strain and three calves infected with the Iowa
strain. These calves had very small amounts of virus in their
serum for one to three days, but virus was isolated from day four
to day nine after infection, at titres up to 104 TcID50/ml serum on
day five from one of the calves infected with the Iowa strain. This
calf died on day 10. Virus was not isolated from any of the serum
samples from the other calves.
After challenge, the control calves shed virus from their noses
from day one to day eight (Fig 3a). In the other groups, small
amounts of virus were isolated from the noses of some of the
calves in each group. Virus was isolated from only three ocular
samples from the control calves. No virus was isolated from any
of the other ocular, genital and serum samples collected after chal-
lenge. The shedding of the challenge virus was reduced equally in
all the groups previously infected with one of the seven strains.
Treatment with dexamethasone induced the excretion of virus
from the noses and the eyes of the calves by day three after the
start of the dexamethasone treatment, with peaks on days five and
six (Fig 3b and 3c). One control calf, one of the calves infected
with the Lam strain, two of the calves infected with the Harberink
strain and two of the calves infected with the Espuna strain did not
shed virus from their nose or eyes after the dexamethasone treat-
ment. Significantly more virus was isolated from the calves infect-
ed with the Cooper- I strain than from the calves infected with the
Harberink strain. No virus could be isolated from the genital and
serum samples collected from any of the calves after their treat-
ment with dexamethasone.
Virus typing
In a few cases the viruses isolated after the infection, after the
challenge and after the treatment with dexamethasone were anal-
ysed by DNA restriction enzyme analysis. With the restriction
enzyme used (EcoRI) the patterns of the DNA fragments of the
viruses isolated after infection were indistinguishable from the
patterns of the original strains (Fig 4, lanes 1 to 9). The patterns of
the viruses isolated after the challenge were indistinguishable
.from the pattern of the challenge strain Iowa (Fig 4, Lanes 10 to
12). The patterns of the EcoRI fragments of the viruses isolated
after the treatment with dexamethasone were indistinguishable
from the patterns of the viruses used for the first infection (Fig 4,
Lanes 13 to 18).
Antibody response
Before the start of the experiment, none of the calves had BHVI
neutralising antibodies. On day 20 after infection all the infected
calves had BHV1 neutralising antibodies (Fig 5) and there were no
org. after after after
strains infect. I chall. dex. treatm.
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FIG 4: Restriction enzyme analysis of the DNA from a selection of
BHV1.1 isolates after infection, challenge or dexamethasone treatment.
The viral DNAs have been digested with the restriction enzyme EcoRI,
separated on a 0-5 per cent agarose gel and stained with ethidium bro-
mide. Lane M: Molecular weight marker. Lanes 1, 2 and 3: DNA of
the original strains, Lam, Harberink and Iowa, respectively. Lanes 4
to 9: DNA from six isolates after the first infection. Lanes 4 and 5:
infected with Lam; lanes 6 and 7: infected with Harberink; and lanes
8 and 9: infected with Iowa. Lanes 10 to 12: DNA from three isolates
after challenge with Iowa. Lane 10: first infected with Lam; lane 11:
first infected with Harberink; and lane 12: first infected with Iowa.
Lanes 13 to 18: DNA from six isolates after dexamethasone treatment.
Lanes 13 and 14: first infected with Lam; lanes 15 and 16: first infect-
ed with Harberink; and lanes 17 and 18: first infected with Iowa. kb =
kilo base pairs
significant differences between the average titres of the seven
groups.
On the day of challenge, the control calves did not have BHVI
neutralising antibodies. The neutralising antibody titres of the
other calves on the day of challenge were as high as the titres on
day 35 after infection and there were no significant differences
between the titres of the different groups. After challenge, BHVI
neutralising antibodies were induced in all the control calves.
Four-fold or higher increases of the antibody titres were detected
in most of the other calves. In nine of the calves the antibody titres
did not increase after challenge, although the virus replicated in
the noses of six of these calves. In eight of the calves there were
significant increases in the antibody titres without detectable virus
replication.
At the start of the treatment with dexamethasone there were no
significant differences between the neutralising antibody titres of
the seven groups of infected calves; the titres in the control calves
were significantly lower. After the dexamethasone treatment,
four-fold or higher increases in the neutralising antibody titres
were detected in 17 of the 24 calves that excreted virus. Six of the
calves did not excrete virus, although in two of them the antibody
titres increased four-fold. At the end of the experiment, the BHV1
neutralising antibody titres of the calves infected with the
Harberink strain were significantly lower than the titres of the
other infected calves. The titres in the calves infected with the
Cooper-I strain were the highest.
Pathological findings
Two of the calves infected with the Iowa strain died on day 10
after infection. They had severe inflammation of the tonsils,
nasal-, pharyngeal- and tracheal mucosae, and degeneration of the
adrenal glands, kidneys and liver. BHV1 was isolated from these
organs. The lungs were normal and pneumonia was not observed.
Staphylococcus aureus and Proteus vulgaris were isolated from
the nasal mucosae of these calves.
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FIG 5: BHV1 neutralising antibody response of the calves. Calves were infected on day 0, the arrows indicate the day of challenge (C) and the
start of the dexamethasone treatment (DMT). Key as in Fig 1
Discussion
The virulence of seven strains of BHVIA. was assessed in order
to find a highly virulent strain for BHVI vaccination-challenge
experiments. Only small differences were expected between the
virulence of the seven strains, so a sensitive test system was
required. Because young calves are more severely affected by
BHVI infections than older cattle (Msolla and others 1983b), the
virulence of the seven strains was studied in two-week-old calves.
Secondary infections can worsen the outcome of a BHVI infec-
tion. A strain of BHVI given at the same dose and by the same
route of infection induced more severe disease in conventionally
raised calves than in specific pathogen-free calves (Kaashoek and
others 1994, 1995). Specific pathogen-free calves were therefore
used to exclude any possible differences in the microbiological
status of the calves.
Clear differences in virulence were observed between the
strains. From the clinical observations, it was concluded that the
calves infected with the Iowa or the EDI strain were most severely
affected. Two of the four calves infected with the Iowa strain died
and two of the four calves infected with the EDI strain were
severely ill for a long time. The total clinical scores for the calves
infected with the Iowa and the EDI strains were much higher than
the total scores for the calves infected with the other strains. The
rectal temperatures also indicated the differences in virulence; the
more virulent strains induced fever for a longer period than the
less virulent strains.
All the seven strains used in the experiment were strains of
BHVI.1. Edwards and others (1991) did not find any differences in
virulence between four strains of BHVI.1, possibly because the four
strains all came from the United Kingdom and had been isolated
within a period of two years (Edwards and others 1990). The
strains studied in this experiment originated from five countries
on two continents and had been isolated over a period of more
than 15 years. They were therefore less likely to be related, and
small genetic differences may explain the differences in virulence.
The virulence of some of the strains has been described.
Mechor and others (1987) used strain 108 to infect 48-hour-old
calves. In that experiment all the seronegative calves died from
the infection, whereas in this experiment strain 108 caused only
moderately severe disease. This difference may have been due to
the differences in the age of the calves at the time of infection, and
to the different routes of infection. Forman and others (1982)
compared intranasal instillation and exposure to an aerosol of the
Colorado-I strain in calves. Lesions of the lower respiratory tract
were more severe in the calves exposed to the aerosol and more
virus was isolated from these calves than from the calves infected
intranasally.
In addition to the clinical score and rectal temperature, attempts
were made to find more objective measures of the severity of the
disease caused by BHV1. The respiratory rate and heart rate of the
calves were recorded and serum iron, zinc and haemoglobin con-
centrations, haematocrit and total leucocyte count were deter-
mined (data not shown). These measurements were very variable
in the two-week-old calves, and the BHVI infections had no signif-
icant effect on them. As a result, it was not possible to use them to
compare the differences in virulence of the different strains.
The shedding of virus from the nose was not correlated with
virulence. Virus was isolated for the same period and at the same
titres from the calves infected with Iowa, a very virulent strain, as
from the calves infected with Harberink, one of the least virulent
strains. The calves infected with strain 108 shed the least virus,
although this strain was not the least virulent. There were no sig-
nificant differences between the seven groups of calves in the
amounts of virus isolated from the ocular and genital mucosae. It
is possible that the genitals were infected either directly or indi-
rectly by a route outside the calf. Nevertheless, virus was isolated
from the genitals of the very young calves but not from the geni-
tals of the 1 8-week-old calves. This observation could support an
age dependent spread of the virus through the body, most likely
through the blood stream. Viraemia was also observed only in the
very young calves and not in the older calves. Viraemia was
observed less often than infection of the genitals, however, possi-
bly because the viraemia is at a low level or short-lived. In the
authors' experiment the calves were sampled only once a day.
Virus was isolated for several days from the serum of the calves
infected with the most virulent strain, Iowa. Brenner and others
(1989) isolated the virus from blood samples taken four days after
a BHVI infection, although the infection induced only a mild clini-
cal effect on the calves. Virus was isolated from many of the
organs of the two calves that died after being infected with the
Iowa strain, and this could also indicate viraemia. Generalised
infections are more commonly reported (Higgins and Edwards
1986, Mechor and others 1987), usually in very young calves. The
occurrence of viraemia probably depends on the virulence of the
strain and the age of the calves.
The Iowa strain was considered to be the most virulent, and it
was therefore used to challenge all the calves to evaluate the
immunogenicity of the different strains. In contrast with their dif-
ferences in virulence, all the seven strains were equally immuno-
genic. After the challenge, no clinical disease was observed and
virus shedding was greatly reduced, whereas the control calves
became ill and shed a lot of virus. The age-dependent susceptibili-
ty to BHvI observed by Msolla and others (1983b) for the Strichen
strain was also observed for the Iowa strain. After infection with
the Iowa strain, the 18-week-old calves had fever for a shorter
period and their total clinical score was significantly lower than in
the two-week-old calves; furthermore, significantly less virus was
isolated from the nasal and ocular mucosae of the older calves and
no virus was isolated from their genitals or sera.
Restriction enzyme analysis of a few isolates after the challenge
showed that the Iowa challenge virus was shed. The challenge did
not reactivate the virus used for the first infection.
After the treatment with dexamethasone, significant differences
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were observed between the groups in the amounts of virus excret-
ed, although all the groups, except the control group, had been
infected and challenged with the same amount of virus. These dif-
ferences were not related to the differences in virulence. The titres
of BHVI neutralising antibody at the start of the dexamethasone
treatment were similar for all the twice-infected groups, and this
titre therefore apparently had no influence on the excretion of
BHVI, as has been suggested by Pastoret and others (1984).
A few isolates obtained after the treatment with dexamethasone
were examined by DNA restriction enzyme analysis and found to
be the strain used for the first infection. This was not an unexpect-
ed finding, because the strain used for the first infection replicated
to much higher titres in the nasal mucosae than the Iowa strain
after challenge.
On the basis of the results of this experiment, the Iowa strain
has been selected for future challenge experiments, and the Lam
strain has been selected as the parental strain for vaccine develop-
ment (Van Engelenburg and others 1994). It was not possible to
identify parameters other than the rectal temperature and the clini-
cal score to measure the severity of the disease caused by an
infection with BHVI.
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Short Communications
Occurrence of resistance to
anthelmintics in sheep in
Parana State, Brazil
V. T. Soccol, C. Sotomaior, F. P. Souza,
E. A. Castro, M. C. Pess6a Silva, V. Milczewski
Veterinari Record (1996) 139, 421-422
IN the past few years, the resistance of gastrointestinal nematodes
to anthelmintics has become common and this can be a major
problem in countries where Haemonchus contortus is endemic. In
countries of the southern hemisphere, surveys have shown a high
V. T. Soccol, C. Sotomaior, F. P. Souza, E. A. Castro, V. Milczewski,
Veterinary Parasitology Laboratory, Basic Pathology Department,
Universidade Federal do Parana J. Americas, Curitiba, Parana, Brazil
M. C. Pess6a Silva, Agriculture and Supplying Secretary of Parana- Rua
dos Funciondrios, 1559, Curitiba, Parana, Brazil
incidence of resistance to the benzimidazoles, imidazothiazoles
and avermectin families in New Zealand (McKenna 1990),
Australia (Eagleson and others 1992), South Africa (van Wyk and
van Schalkwyk 1990) and South America (Nari 1987).
In the southern Brazilian State of Rio Grande do Sul, there have
been reports of Haemonchus, Trichostrongylus and Nematodirus
species resistant to benzimidazoles, rafoxanide and ivermectin
(Amaral 1985, Echevarria and Trindade 1989, Echevarria 1995).
In a recent survey, multiple resistance was found in Argentina,
Brazil, Paraguay and Uruguay and the percentage of resistance to
levamisole was: 32, 84, 68 and 70 per cent; to benzimidazole: 40,
90, 73 and 86 per cent and to ivermectin: 6, 13, 73 and 12 per
cent, respectively (Nari 1995).
In Parana State, intensive sheep breeding has been developed in
recent years through government sponsored sheep farm develop-
ment. Sheep are maintained under intensive or semi-intensive sys-
tems at high density and with a suppressive anthelmintic pro-
gramme. Acute clinical haemonchosis with a high percentage of
mortality are not uncommon. The present study was undertaken to
determine if these cases were associated with anthelmintic resis-
tance.
Six sheep flocks with a history of apparent anthelmintic failure
were selected for the trial. The farms were located in the follow-
ing regions of Parana State: eastern - Castro and Campo Largo;
421
 group.bmj.com on December 14, 2011 - Published by veterinaryrecord.bmj.comDownloaded from 
doi: 10.1136/vr.139.17.416
 1996 139: 416-421Veterinary Record
 
M. J. Kaashoek, P. J. Straver, E. M. A. Van Rooij, et al.
 
clinical and virological aspects
of seven bovine herpesvirus 1.1 strains: 
Virulence, immunogenicity and reactivation
 http://veterinaryrecord.bmj.com/content/139/17/416
Updated information and services can be found at: 
These include:
References
 http://veterinaryrecord.bmj.com/content/139/17/416#related-urls
Article cited in: 
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on December 14, 2011 - Published by veterinaryrecord.bmj.comDownloaded from 
